Myoendothelial communication in the renal vasculature and the impact of drugs used clinically to treat hypertension

Publikation: Bidrag til tidsskriftReviewForskningfagfællebedømt

Standard

Myoendothelial communication in the renal vasculature and the impact of drugs used clinically to treat hypertension. / Sorensen, Charlotte Mehlin; Cupples, William A.

I: Current Opinion in Pharmacology, Bind 45, 2019, s. 49-56.

Publikation: Bidrag til tidsskriftReviewForskningfagfællebedømt

Harvard

Sorensen, CM & Cupples, WA 2019, 'Myoendothelial communication in the renal vasculature and the impact of drugs used clinically to treat hypertension', Current Opinion in Pharmacology, bind 45, s. 49-56. https://doi.org/10.1016/j.coph.2019.04.005

APA

Sorensen, C. M., & Cupples, W. A. (2019). Myoendothelial communication in the renal vasculature and the impact of drugs used clinically to treat hypertension. Current Opinion in Pharmacology, 45, 49-56. https://doi.org/10.1016/j.coph.2019.04.005

Vancouver

Sorensen CM, Cupples WA. Myoendothelial communication in the renal vasculature and the impact of drugs used clinically to treat hypertension. Current Opinion in Pharmacology. 2019;45:49-56. https://doi.org/10.1016/j.coph.2019.04.005

Author

Sorensen, Charlotte Mehlin ; Cupples, William A. / Myoendothelial communication in the renal vasculature and the impact of drugs used clinically to treat hypertension. I: Current Opinion in Pharmacology. 2019 ; Bind 45. s. 49-56.

Bibtex

@article{bb23d6ba86944748be9e1a8b4aef7951,
title = "Myoendothelial communication in the renal vasculature and the impact of drugs used clinically to treat hypertension",
abstract = "The renal vasculature has many peculiarities including highly irregular branching. Renal blood flow must sustain adequate perfusion and maintain a high glomerular filtration. Renal autoregulation helps control renal blood flow. The local autoregulatory mechanism, tubuloglomerular feedback, elicits a vasoconstriction that can be found not only in neighboring nephrons but over large areas of the kidney indicating that the renal vasculature supports strong conduction of vascular responses. The basis for conduction is intercellular communication through gap junctions. The endothelium is strongly coupled and serves as a vascular conduction highway leading the signal to the vascular smooth muscle cells through myoendothelial coupling. Extensive intercellular coupling is also found in renin secreting cells where gap junctions seem to tie the cells together to improve control of renin secretion. Lack of coupling leads to dysregulation of renin secretion and hypertension. However, the activity of the renin-angiotensin system also controls gap junction expression in the kidney. Treatment reducing angiotensin II activity, as used in hypertension treatment, can affect expression of renal and vascular gap junction.",
author = "Sorensen, {Charlotte Mehlin} and Cupples, {William A}",
note = "Copyright {\textcopyright} 2019 Elsevier Ltd. All rights reserved.",
year = "2019",
doi = "10.1016/j.coph.2019.04.005",
language = "English",
volume = "45",
pages = "49--56",
journal = "Current Opinion in Pharmacology",
issn = "1471-4892",
publisher = "Elsevier Ltd. * Current Opinion Journals",

}

RIS

TY - JOUR

T1 - Myoendothelial communication in the renal vasculature and the impact of drugs used clinically to treat hypertension

AU - Sorensen, Charlotte Mehlin

AU - Cupples, William A

N1 - Copyright © 2019 Elsevier Ltd. All rights reserved.

PY - 2019

Y1 - 2019

N2 - The renal vasculature has many peculiarities including highly irregular branching. Renal blood flow must sustain adequate perfusion and maintain a high glomerular filtration. Renal autoregulation helps control renal blood flow. The local autoregulatory mechanism, tubuloglomerular feedback, elicits a vasoconstriction that can be found not only in neighboring nephrons but over large areas of the kidney indicating that the renal vasculature supports strong conduction of vascular responses. The basis for conduction is intercellular communication through gap junctions. The endothelium is strongly coupled and serves as a vascular conduction highway leading the signal to the vascular smooth muscle cells through myoendothelial coupling. Extensive intercellular coupling is also found in renin secreting cells where gap junctions seem to tie the cells together to improve control of renin secretion. Lack of coupling leads to dysregulation of renin secretion and hypertension. However, the activity of the renin-angiotensin system also controls gap junction expression in the kidney. Treatment reducing angiotensin II activity, as used in hypertension treatment, can affect expression of renal and vascular gap junction.

AB - The renal vasculature has many peculiarities including highly irregular branching. Renal blood flow must sustain adequate perfusion and maintain a high glomerular filtration. Renal autoregulation helps control renal blood flow. The local autoregulatory mechanism, tubuloglomerular feedback, elicits a vasoconstriction that can be found not only in neighboring nephrons but over large areas of the kidney indicating that the renal vasculature supports strong conduction of vascular responses. The basis for conduction is intercellular communication through gap junctions. The endothelium is strongly coupled and serves as a vascular conduction highway leading the signal to the vascular smooth muscle cells through myoendothelial coupling. Extensive intercellular coupling is also found in renin secreting cells where gap junctions seem to tie the cells together to improve control of renin secretion. Lack of coupling leads to dysregulation of renin secretion and hypertension. However, the activity of the renin-angiotensin system also controls gap junction expression in the kidney. Treatment reducing angiotensin II activity, as used in hypertension treatment, can affect expression of renal and vascular gap junction.

U2 - 10.1016/j.coph.2019.04.005

DO - 10.1016/j.coph.2019.04.005

M3 - Review

C2 - 31071677

VL - 45

SP - 49

EP - 56

JO - Current Opinion in Pharmacology

JF - Current Opinion in Pharmacology

SN - 1471-4892

ER -

ID: 225427993